Reuters logo
BRIEF-Walvax Biotechnology unit receives GMP certificate
April 24, 2017 / 2:19 AM / 5 months ago

BRIEF-Walvax Biotechnology unit receives GMP certificate

April 24 (Reuters) - Walvax Biotechnology Co Ltd :

* Says its wholly owned subsidiary received goods manufacture practice (GMP) certificate from Yunnan Food and Drug Administration

* Certificate issued pneumococcal polysaccharide vaccine manufactured by the unit and the valid period is until April 18, 2022

Source text in Chinese: goo.gl/5GHaZZ

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below